• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    Catabasis Announces Proposed Underwritten Public Offering

    Danielle Edwards
    Jan. 30, 2020 05:57AM PST
    Pharmaceutical Investing

    Catabasis announced that it intends to offer its securities in an underwritten public offering, subject to market and other conditions.

    Catabasis Pharmaceuticals (NASDAQ:CATB) announced that it intends to offer its securities in an underwritten public offering, subject to market and other conditions.

    As quoted in the press release:

    Oppenheimer & Co. Inc. is acting as sole underwriter for the offering.

    Catabasis intends to use the net proceeds from the offering for clinical trial and other research and development activities; initial commercialization preparations; and for working capital and other general corporate purposes.

    The securities described above will be offered pursuant to a shelf registration statement on Form S-3 (No. 333-231441), which was previously filed with and declared effective by the Securities and Exchange Commission (“SEC”) on May 23, 2019.

    Click here to read the full press release.

    pharmaceutical investingnasdaq:catbcatabasis pharmaceuticals
    The Conversation (0)

    Go Deeper

    AI Powered
    Canada maple leaves on left and pharmaceutical pills in red and blue on right.

    4 Best-performing Canadian Pharma Stocks (Updated October 2024)

    Vitae Pharmaceuticals Prices Public Offering of Common Stock

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    Invion Limited

    IVX:AU

    Cardiol Therapeutics

    CRDL:CA
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×